Is Berberine Insulin Resistance Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Berberine Insulin Resistance Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Diabetes mellitus and prediabetes represent major global health challenges associated with metabolic and cardiovascular complications. [Nampalliwar A (2026); evidence level 1] - This review was conducted to evaluate herbal medicines as complementary strategies for glycaemic control and metabolic risk reduction. [Nampalliwar A (2026); evidence level 1] - Evidence demonstrated that high-fat diets, in particular saturated fats, elevate plasma ceramide levels, which are strongly associated with insulin resistance and T2DM. [Collins K (2026); evidence level 3] - Collectively, the evidence supports a mechanistic and associative link between ceramides and T2DM. [Collins K (2026); evidence level 3] - It highlights the emerging potential of plasma ceramides as biomarkers for insulin resistance and disease risk. [Collins K (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.